 |
 |
|
|
|
|
|
|
2006
- Allocated new stock to a third-party.
- Established SNBL USA Scientific Resources Center in Texas, USA.
2005
- Wakayama PBC hosts a GLP inspection for Organization of Pharmaceuticals
by the Ministry of Agriculture, Forestry and Fisheries (Received "A"
grading).
- Sixth GLP inspection based on Chemicals Inspection Law was conducted (Approved).
- SNBL stock went through a 2-for-1 split.
- SNBL CPC, Inc., a phase I clinical trial facility, opened in the Biopark
of University of Maryland, Baltimore, USA.
- Establishes a general partnership with Biomarker Science in the field of
Preventative Medicine and General Medical Therapy.
- Translational Research, Ltd., signs a Term Sheet with Tokai Pharmaceuticals,
Inc. (located in Cambridge, MA, USA), for the license to use TRL's nasal
delivery technology and for the purchase of nasal delivery devices from
Bioactis, Ltd.
- Safety Research Facility in Kagoshima, Japan, opened a new lab building.
- Issued new stock for public offering.
2004
- SNBL completed IPO in the Mothers (Market of High-Growth and Emerging Stocks)
of Tokyo Stock Exchange.
- SNBL and the University of Kagoshima, Faculty of Medicine established a
joint curriculum, where SNBL provides lectures and offers donations.
- SNBL and Osaka City University established a research collaboration for
the prevention and treatment of higher brain function disorders.
- SNBL and Tranzyme Pharma Inc. began joint research for a disease-animal
model using primate experiment animals.
- SNBL and the St. Marianna University School of Medicine and SNBL agreed
to establish a mutual venture, where SNBL offers donations.
- Expanded the primate facility in SNBL U.S.A., Ltd. as part of plan to expand
operations in the U.S.A.
- The first phase of construction of the SNBL CHINA, Ltd facility was completed.
2003
- SNBL Headquarters was moved to a new location in Tokyo.
- SNBL and Univeristy of Hokkaido department of pharmacology establishes
a joint curriculum, where SNBL offers donations and lecturers.
- Clinical Pharmacology Center's SMO Headquarters moved to Kobe.
- Clinical Pharmacology Center's SMO Office in Hiroshima was added as an
expansion of SMO Operations.
- SNBL CHINA, Ltd. was established in Guangdong, China, with its head office
located in Hong Kong.
- SNBL was awarded "54th South Japan Cultural Award" by South Japan
Newspaper.
2002
- Safety Research Facility expanded.
- Research Facility in Pharmacokinetics and Bioanalysis Center expanded.
- Fourth facility extension was completed in SNBL U.S.A., Ltd.
2001
- Third facility extension was completed in SNBL U.S.A., Ltd.
- Launch of SNBL Clinical Pharmacology Center in Kobe City.
- BMT Hybrid, a joint medical bioventure, was established between SNBL and
Kagoshima University professors.
- New SNBL Headquarters building was completed.
2000
- A joint enterprise, UMI, LLC (University Medicines International, LLC)
was established between Maryland State University and SNBL to perform contract
Phase II/III clinical studies.
- GenKey, Ltd., a medical consulting company, was established in London and
reg.123.com, Ltd., an Internet portal, was set up.
- RALS (a mobile/remote access service) was introduced into Clinical Development
Division, which allowed access to LAN from each monitor terminal under
a new strict security system (First system built by NTT in Japan).
1999
- Biosupport. Inc. (Redmond, Washington, U.S.A.) was acquired.
- SNBL U.S.A., Ltd. was moved to Everett, Washington and Safety Research
Facility was constructed at the site.
- Grand Prize for Industry and Economy for 1998 was awarded by Kagoshima
Chamber of Commerce.
- Fourth GLP inspection based on Chemicals Inspection Law was conducted (Approved).
1998
- Windows NT environment system was introduced into the computer system (intranet).
- A television conference system was introduced into all offices of the Group.
- Pharmacokinetics and Bioanalysis Center was established in Kainan City,
Wakayama Prefecture.
- Second GLP inspection was conducted by the Organization of Pharmaceuticals
(the Ministry of Health and Welfare) (Received "A" grading).
1997
- Clinical Development Division was established and contract of Phase II
and III clinical studies started.
- Pharmacology Research Facility expanded.
- Prize for Contribution of Company Towards Community Vitalization for 1996
was awarded by Nihon Keizai Shimbun, Inc. (cosponsored by National Land
Agency).
- Fourth GLP inspection for agricultural chemicals was conducted by the Ministry
of Agriculture, Forestry and Fisheries (Approved).
1996
- First electronic submission for new drug application was submitted to the
Ministry of Health and Welfare (first test case in Japan).
- Osaka Branch Office was moved to Fushimi-machi (Kitahama), Chuo-ku, Osaka.
- Third GLP inspection based on Chemicals Inspection Law was conducted (Approved).
- Third GLP inspection was conducted by the Ministry of Labour (Approved).
1995
- Operation of Intranet started.
- Prize for Creation of Margin for '94 was awarded by National Federation
of Labour Standards Association.
- First GLP inspection was conducted by the Organization of Pharmaceuticals
(the Ministry of Health and Welfare) (Received "A" grading).
1994
- Reinforcement of the computer system (intranet) started.
- Safety Research Facility expanded.
- Third GLP inspection for agricultural chemicals was conducted by the the
Ministry of Agriculture, Forestry and Fisheries (Approved).
1993
- SNBL Clinical Pharmacology Center was established and contract clinical
pharmacology trials started.
- Second GLP inspection was conducted by the Ministry of Labor (Approved).
1992
- Safety Research Facility expanded.
- Second GLP inspection based on Chemical Inspection Law was conducted (Approved).
1991
- Ryoichi Nagata named president of SNBL.
- U.S.A. and U.K. Representative Offices became independent subsidiaries
and were named as SNBL U.S.A., Ltd. and SNBL U.K., Ltd., respectively.
- Second GLP inspection for agricultural chemicals was conducted by the Ministry
of Agriculture, Forestry and Fisheries (Approved).
- Third GLP inspection was conducted by the Ministry of Health and Welfare
("A" grading awarded).
1990
- Pathology Research Facility was constructed.
- U.K. Representative Office was established in the suburbs of London.
- U.S.A. Representative Office was relocated to Virginia.
- First GLP inspection based on Chemical Inspection Law was conducted by
the Ministry of International Trade and Industry (Approved).
- First GLP inspection was conducted by the Ministry of Labor (Approved).
- First GLP inspection for animal drugs was conducted by the Ministry of
Agriculture, Forestry and Fisheries (Received "A" grading).
1989
- Osaka Branch Office was established.
- Safety Research Facility expanded.
- Original computer network system, LAN system using VAN (DEC) as the host
computer and Macintosh (Apple) PCs as workstations, was completed (The
first DTP system in Japan).
- General Headquarters was established.
1988
- U.S.A. Representative Office was established in Maryland.
- First GLP inspection for agricultural chemicals was conducted by the Ministry
of Agriculture, Forestry and Fisheries (Approved).
1987
- Pharmacology Research Facility was constructed.
- Second GLP inspection was conducted by the Ministry of Health and Welfare
("A" grading awarded).
1986
- Safety Research Facility expanded.
- Inhalation Research Facility expanded.
1985
- The computer system was upgraded and development of peripheral software
started.
- Inhalation Research Facility was constructed.
1984
- First GLP inspection was conducted by the Ministry of Health and Welfare
("A" grading awarded).
1983
- Compliance with the GLP standards of the Ministry of Health and Welfare.
1982
- MITOX, industry's first networked computer system, was introduced for data
collection in safety studies.
- Safety Research Facility expanded.
1980
- The Safety Research and Administration Facility was constructed and the
business became concentrated on contract safety studies.
1977
- Tokyo Branch Office was established.
1974
- Company was incorporated and changed its name to Shin Nippon Biomedical
Laboratories, Ltd.
1960
- First contract safety study conducted.
1957
- The forerunner of the present Shin Nippon Biomedical Laboratories, Ltd.,
was founded by Tsugio Nagata.
|
|
